Page last updated: 2024-11-05

tolazoline and Cerebral Infarction

tolazoline has been researched along with Cerebral Infarction in 1 studies

Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FAZEKAS, JF1
ALMAN, RW1

Other Studies

1 other study available for tolazoline and Cerebral Infarction

ArticleYear
THERAPEUTIC MODALITIES IN THE MANAGEMENT OF CEREBRAL VASCULAR INSUFFICIENCY.
    American heart journal, 1963, Volume: 66

    Topics: Anticoagulants; Brain Ischemia; Cerebral Infarction; Cerebrovascular Disorders; Classification; Hist

1963